Mechanisms of disseminated cancer cell dormancy: An awakening field

Nature Reviews Cancer

Volumn 14, Issue 9, 2014, Pages 611-622

  Sosa, María Soledad ^a,b   Bragado, Paloma ^a,b,c   Aguirre Ghiso, Julio A ^a,b  

^a Tisch Cancer Institute   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY; CANCER CELL; CANCER GROWTH; CELL DIVISION; CELL DORMANCY; CELL STRESS; DISSEMINATED CANCER; DISSEMINATED CANCER CELL; HUMAN; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

AUTOPHAGY; EPIGENESIS, GENETIC; HUMANS; NEOPLASM, RESIDUAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84906937205     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3793     Document Type: Review

References (153)

1. Klein, C. A. Framework models of tumor dormancy from patient-derived observations. Curr. Opin. Genet. Dev. 21, 42-49 (2010
2. Goss, P. E. & Chambers, A. F. Does tumour dormancy offer a therapeutic target?. Nature Rev. Cancer 10, 871-877 (2010
3. Klein, C. A. Selection and adaptation during metastatic cancer progression. Nature 501, 365-372 (2013
4. Aguirre-Ghiso, J. A. Models, mechanisms and clinical evidence for cancer dormancy. Nature Rev. Cancer 7, 834-846 (2007
5. Demicheli, R. et al. Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Ann. Oncol. 16, 1449-1457 (2005
6. Hadfield, G. The dormant cancer cell. Br. Med. J. 2, 607-610 (1954
7. Pantel, K., Alix-Panabieres, C. & Riethdorf, S. Cancer micrometastases. Nature Rev. Clin. Oncol. 6, 339-351 (2009
8. Pantel, K. & Brakenhoff, R. H. Dissecting the metastatic cascade. Nature Rev. Cancer 4, 448-456 (2004
9. Klein, C. A. Parallel progression of primary tumours and metastases. Nature Rev. Cancer 9, 302-312 (2009
10. Essers, M. A. & Trumpp, A. Targeting leukemic stem cells by breaking their dormancy. Mol. Oncol. 4, 443-450 (2010
11. Sosa, M. S., Avivar-Valderas, A., Bragado, P., Wen, H. C. & Aguirre-Ghiso, J. A. ERK1/2 and p38α/β signaling in tumor cell quiescence: Opportunities to control dormant residual disease. Clin. Cancer Res. 17, 5850-5857 (2011
12. Kang, Y. & Pantel, K. Tumor cell dissemination: Emerging biological insights from animal models and cancer patients. Cancer Cell 23, 573-581 (2013
13. Giancotti, F. G. Mechanisms governing metastatic dormancy and reactivation. Cell 155, 750-764 (2013
14. Jo, H., Jia, Y., Subramanian, K. K., Hattori, H. & Luo, H. R. Cancer cell-derived clusterin modulates the phosphatidylinositol 3'-kinase-Akt pathway through attenuation of insulin-like growth factor 1 during serum deprivation. Mol. Cell. Biol. 28, 4285-4299 (2008
15. Humtsoe, J. O. & Kramer, R. H. Differential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway. Oncogene 29, 1214-1226 (2010
16. Balz, L. M. et al. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC γ1 signalling in breast cancer cell migration and dissemination. J. Pathol. 227, 234-244 (2012
17. Schewe, D. M. & Aguirre-Ghiso, J. A. ATF6α Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. Proc. Natl Acad. Sci. USA 105, 10519-10524 (2008
18. Bragado, P. et al. TGF β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling. Nature Cell Biol. 15, 1351-1361 (2013
19. Lu, X. et al. VCAM 1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1 positive osteoclast progenitors. Cancer Cell 20, 701-714 (2011
20. Aslakson, C. J. & Miller, F. R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52, 1399-1405 (1992
21. Aslakson, C. J., Rak, J. W., Miller, B. E. & Miller, F. R. Differential influence of organ site on three subpopulations of a single mouse mammary tumor at two distinct steps in metastasis. Int. J. Cancer 47, 466-472 (1991
22. Avivar-Valderas, A. et al. Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. Oncogene 32, 4932-4940 (2013
23. Correa, R. J., Peart, T., Valdes, Y. R., DiMattia, G. E. & Shepherd, T. G. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids. Carcinogenesis 33, 49-58 (2012
24. Lengyel, E. Ovarian cancer development and metastasis. Am. J. Pathol. 177, 1053-1064 (2010
25. Lu, Z. et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J. Clin. Invest. 118, 3917-3929 (2008
26. Gupta, A. et al. Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST). Proc. Natl Acad. Sci. USA 107, 14333-14338 (2010
27. Lee, I. H. et al. Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress. Science 336, 225-228 (2012
28. Mortensen, M. et al. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J. Exp. Med. 208, 455-467 (2011
29. Avivar-Valderas, A. et al. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol. Cell. Biol. 31, 3616-3629 (2011
30. Liang, J. et al. The energy sensing LKB1 AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nature Cell Biol. 9, 218-224 (2007
31. Schewe, D. M. & Aguirre-Ghiso, J. A. Inhibition of eIF2α dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy. Cancer Res. 69, 1545-1552 (2009
32. Fan, W. et al. MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agents. Cancer Res. 71, 4494-4505 (2011
33. Alvarez, J. V. et al. Par 4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy. Cancer Cell 24, 30-44 (2013
34. Deng, X., Ewton, D. Z. & Friedman, E. Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by reducing levels of reactive oxygen species. Cancer Res. 69, 3317-3324 (2009
35. Jin, K., Ewton, D. Z., Park, S., Hu, J. & Friedman, E. Mirk regulates the exit of colon cancer cells from quiescence. J. Biol. Chem. 284, 22916-22925 (2009
36. Ewton, D. Z. et al. Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells. Mol. Cancer Ther. 10, 2104-2114 (2011
37. Hu, J., Nakhla, H. & Friedman, E. Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2. Int. J. Cancer 129, 307-318 (2011
38. Jin, K., Park, S., Ewton, D. Z. & Friedman, E. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer. Cancer Res. 67, 7247-7255 (2007
39. Litovchick, L., Florens, L. A., Swanson, S. K., Washburn, M. P. & DeCaprio, J. A. DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. Genes Dev. 25, 801-813 (2011
40. Lopez-Maury, L., Marguerat, S. & Bahler, J. Tuning gene expression to changing environments: From rapid responses to evolutionary adaptation. Nature Rev. Genet. 9, 583-593 (2008
41. Chatterjee, M. & van Golen, K. L. Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype. Int. J. Cancer 129, 61-69 (2011
42. Hickson, J. A. et al. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res. 66, 2264-2270 (2006
43. Vander Griend, D. J. et al. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2 terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res. 65, 10984-10991 (2005
44. Adam, A. P. et al. Computational identification of a p38SAPK regulated transcription factor network required for tumor cell quiescence. Cancer Res. 69, 5664-5672 (2009
45. Hickson, J. A. et al. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res. 66, 2264-2270 (2006
46. El Touny, L. H. et al. Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells. J. Clin. Invest. 124, 156-168 (2014
47. Diehl, N. L. et al. Activation of the p38 mitogen-Activated protein kinase pathway arrests cell cycle progression and differentiation of immature thymocytes in vivo. J. Exp. Med. 191, 321-334 (2000
48. Masiero, M. et al. Notch3 mediated regulation of MKP 1 levels promotes survival of T acute lymphoblastic leukemia cells. Leukemia 25, 588-598 (2011
49. Walter, P. & Ron, D. The unfolded protein response: From stress pathway to homeostatic regulation. Science 334, 1081-1086 (2011
50. Ranganathan, A. C., Zhang, L., Adam, A. P. & Aguirre-Ghiso, J. A. Functional coupling of p38 induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res. 66, 1702-1711 (2006
51. Fu, Y., Li, J. & Lee, A. S. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res. 67, 3734-3740 (2007
52. Bartkowiak, K. et al. Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients. J. Proteome Res. 9, 3158-3168 (2010
53. Bartkowiak, K. et al. Two-dimensional differential gel electrophoresis of a cell line derived from a breast cancer micrometastasis revealed a stem/ progenitor cell protein profile. J. Proteome Res. 8, 2004-2014 (2009
54. Bi, M. et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J. 24, 3470-3481 (2005
55. Spencer, J. A. et al. Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature 508, 269-273 (2014
56. Elanchezhian, R. et al. Low glucose under hypoxic conditions induces unfolded protein response and produces reactive oxygen species in lens epithelial cells. Cell Death Dis. 3, e301 (2012
57. Badiola, N. et al. Induction of ER stress in response to oxygen-glucose deprivation of cortical cultures involves the activation of the PERK and IRE 1 pathways and of caspase 12. Cell Death Dis. 2, e149 (2011
58. Lee, E. et al. GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Cancer Res. 66, 7849-7853 (2006
59. Bambang, I. F. et al. Cytokeratin 19 regulates endoplasmic reticulum stress and inhibits ERp29 expression via p38 MAPK/XBP 1 signaling in breast cancer cells. Exp. Cell Res. 315, 1964-1974 (2009
60. Murrell, D. H., Foster, P. J. & Chambers, A. F. Brain metastases from breast cancer: Lessons from experimental magnetic resonance imaging studies and clinical implications. J. Mol. Med. 92, 5-12 (2014
61. Heyn, C. et al. In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn. Reson. Med. 56, 1001-1010 (2006
62. Naumov, G. N. et al. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res. Treat 82, 199-206 (2003
63. Aguirre-Ghiso, J. A., Bragado, P. & Sosa, M. S. Metastasis awakening: Targeting dormant cancer. Nature Med. 19, 276-277 (2013
64. Bragado, P., Sosa, M. S., Keely, P., Condeelis, J. & Aguirre-Ghiso, J. A. Microenvironments dictating tumor cell dormancy. Recent Results Cancer Res. 195, 25-39 (2012
65. Schardt, J. A. et al. Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell 8, 227-239 (2005
66. Husemann, Y. et al. Systemic spread is an early step in breast cancer. Cancer Cell 13, 58-68 (2008
67. Shiozawa, Y., Havens, A. M., Pienta, K. J. & Taichman, R. S. The bone marrow niche: Habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites. Leukemia 22, 941-950 (2008
68. Shiozawa, Y. et al. Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasis. J. Cell. Biochem. 114, 2471-2478 (2013
69. Joseph, J. et al. Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotype. Mol. Cancer Res.: MCR 10, 282-292 (2012
70. Shiozawa, Y. et al. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J. Clin. Invest. 121, 1298-1312 (2011
71. Kobayashi, A. et al. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J. Exp. Med. 208, 2641-2655 (2011
72. Gao, H. et al. The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell 150, 764-779 (2012
73. Dormady, S. P., Zhang, X. M. & Basch, R. S. Hematopoietic progenitor cells grow on 3T3 fibroblast monolayers that overexpress growth arrest-specific gene 6 (GAS6). Proc. Natl Acad. Sci. USA 97, 12260-12265 (2000
74. Shiozawa, Y. et al. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. Neoplasia 12, 116-127 (2010
75. Aguirre-Ghiso, J. A., Estrada, Y., Liu, D. & Ossowski, L. ERKMAPK activity as a determinant of tumor growth and dormancy; regulation by p38SAPK. Cancer Res. 63, 1684-1695 (2003
76. Aguirre-Ghiso, J. A., Ossowski, L. & Rosenbaum, S. K. Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res. 64, 7336-7345 (2004
77. Liu, W. et al. N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis. EMBO Mol. Med. 4, 93-108 (2012
78. Talmadge, J. E. & Fidler, I. J. AACR centennial series: The biology of cancer metastasis: Historical perspective. Cancer Res. 70, 5649-5669 (2010
79. Marshall, J. C. et al. Effect of inhibition of the lysophosphatidic Acid receptor 1 on metastasis and metastatic dormancy in breast cancer. J. Natl Cancer Inst. 104, 1306-1319 (2012
80. Ghajar, C. M. et al. The perivascular niche regulates breast tumour dormancy. Nature Cell Biol. 15, 807-817 (2013
81. Malanchi, I. et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85-89 (2012
82. Barkan, D. et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res. 68, 6241-6250 (2008
83. Cheng, G., Tse, J., Jain, R. K. & Munn, L. L. Micro-environmental mechanical stress controls tumor spheroid size and morphology by suppressing proliferation and inducing apoptosis in cancer cells. PLoS ONE 4, e4632 (2009
84. Liu, D., Aguirre Ghiso, J., Estrada, Y. & Ossowski, L. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1, 445-457 (2002
85. Aguirre Ghiso, J. A. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 21, 2513-2524 (2002
86. Shibue, T. & Weinberg, R. A. Integrin β1 focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc. Natl Acad. Sci. USA 106, 10290-10295 (2009
87. Schrader, J. et al. Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology 53, 1192-1205 (2011
88. Barkan, D. et al. Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res. 70, 5706-5716 (2010
89. Swartz, M. A. et al. Tumor microenvironment complexity: Emerging roles in cancer therapy. Cancer Res. 72, 2473-2480 (2012
90. Shiao, S. L., Ganesan, A. P., Rugo, H. S. & Coussens, L. M. Immune microenvironments in solid tumors: New targets for therapy. Genes Dev. 25, 2559-2572 (2011
91. MacKie, R. M., Reid, R. & Junor, B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. New Engl. J. Med. 348, 567-568 (2003
92. Eyles, J. et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J. Clin. Invest. 120, 2030-2039 (2010
93. Koebel, C. M. et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450, 903-907 (2007
94. Muller-Hermelink, N. et al. TNFR1 signaling and IFN-γ signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 13, 507-518 (2008
95. Zhao, X. et al. Vaccines targeting tumor blood vessel antigens promote CD8+ T cell-dependent tumor eradication or dormancy in HLA A2 transgenic mice. J. Immunol. 188, 1782-1788 (2012
96. Braumuller, H. et al. T-helper 1 cell cytokines drive cancer into senescence. Nature 494, 361-365 (2013
97. Holmgren, L., O'Reilly, M. S. & Folkman, J. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149-153 (1995
98. Almog, N. et al. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Cancer Res. 69, 836-844 (2009
99. Almog, N. et al. Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis. FASEB J.: Official Publ. Feder. Am. Societies Exp. Biol. 20, 947-949 (2006
100. Hsu, S. C. et al. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin 1. Cancer Res. 56, 5684-5691 (1996
101. Weinstat-Saslow, D. L. et al. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res. 54, 6504-6511 (1994
102. Indraccolo, S. et al. Cross-Talk between tumor and endothelial cells involving the Notch3 Dll4 interaction marks escape from tumor dormancy. Cancer Res. 69, 1314-1323 (2009
103. Panigrahy, D. et al. Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J. Clin. Invest. 122, 178-191 (2012
104. Pencheva, N. et al. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8 dependent melanoma metastasis and angiogenesis. Cell 151, 1068-1082 (2012
105. Magnus, N. et al. Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations. Proc. Natl Acad. Sci. USA 111, 3544-3549 (2014
106. Wells, A., Griffith, L., Wells, J. Z. & Taylor, D. P. The dormancy dilemma: Quiescence versus balanced proliferation. Cancer Res. 73, 3811-3816 (2013
107. Taylor, D. P., Wells, J. Z., Savol, A., Chennubhotla, C. & Wells, A. Modeling boundary conditions for balanced proliferation in metastatic latency. Clin. Cancer Res. 19, 1063-1070 (2013
108. Kienast, Y. et al. Real-Time imaging reveals the single steps of brain metastasis formation. Nature Med. 16, 116-122 (2010
109. Taichman, R. S. et al. GAS6 receptor status is associated with dormancy and bone metastatic tumor formation. PloS ONE 8, e61873 (2013
110. Tsai, H. C. et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell 21, 430-446 (2012
111. Kim, R. S. et al. Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer. PloS ONE 7, e35569 (2012
112. Dono, M. et al. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: Detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma. Br. J. Cancer 110, 1058-1065 (2014
113. Landreville, S. et al. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin. Cancer Res. 18, 408-416 (2012
114. Chen, T. et al. An RNA interference screen uncovers a new molecule in stem cell self-renewal and long-Term regeneration. Nature 485, 104-108 (2012
115. Kobielak, K., Stokes, N., de la Cruz, J., Polak, L. & Fuchs, E. Loss of a quiescent niche but not follicle stem cells in the absence of bone morphogenetic protein signaling. Proc. Natl Acad. Sci. USA 104, 10063-10068 (2007
116. Avagyan, S., Glouchkova, L., Choi, J. & Snoeck, H. W. A quantitative trait locus on chromosome 4 affects cycling of hematopoietic stem and progenitor cells through regulation of TGF β2 responsiveness. J. Immunol. 181, 5904-5911 (2008
117. Langer, J. C., Henckaerts, E., Orenstein, J. & Snoeck, H. W. Quantitative trait analysis reveals transforming growth factor beta2 as a positive regulator of early hematopoietic progenitor and stem cell function. J. Exp. Med. 199, 5-14 (2004
118. Wilson, A., Laurenti, E. & Trumpp, A. Balancing dormant and self-renewing hematopoietic stem cells. Curr. Opin. Genet. Dev. 19, 461-468 (2009
119. Wilson, A. et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135, 1118-1129 (2008
120. White, A. C. et al. Stem cell quiescence acts as a tumour suppressor in squamous tumours. Nature Cell Biol. 16, 99-107 (2014
121. Onder, T. T. et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 483, 598-602 (2012
122. Gupta, P. B. et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, 633-644 (2011
123. Hanna, J. et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595-601 (2009
124. Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428 (2009
125. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008
126. Chaffer, C. L. et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154, 61-74 (2013
127. Bragado, P. et al. Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties. PloS ONE 7, e29974 (2012
128. Ito, K. et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nature Med. 12, 446-451 (2006
129. Marion, R. M. et al. A p53 mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149-1153 (2009
130. Guo, W. et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148, 1015-1028 (2012
131. Cheung, T. H. & Rando, T. A. Molecular regulation of stem cell quiescence. Nature Rev. Mol. Cell Biol. 14, 329-340 (2013
132. Klein, C. A. et al. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc. Natl Acad. Sci. USA 96, 4494-4499 (1999
133. Schmidt-Kittler, O. et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc. Natl Acad. Sci. USA 100, 7737-7742 (2003
134. Smits, B. M. et al. The gene desert mammary carcinoma susceptibility locus Mcs1a regulates Nr2f1 modifying mammary epithelial cell differentiation and proliferation. PLoS Genet. 9, e1003549 (2013
135. Marino, N. et al. Breast cancer metastasis: Issues for the personalization of its prevention and treatment. Am. J. Pathol. 183, 1084-1095 (2013
136. Steeg, P. S. Perspective: The right trials. Nature 485, S58-59 (2012
137. Alix-Panabieres, C., Muller, V. & Pantel, K. Current status in human breast cancer micrometastasis. Curr. Opin. Oncol. 19, 558-563 (2007
138. Braun, S. et al. A pooled analysis of bone marrow micrometastasis in breast cancer. New Engl. J. Med. 353, 793-802 (2005
139. Jauch, K. W. et al. Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J. Clin. Oncol. 14, 1810-1817 (1996
140. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646-674 (2011
141. Kouros-Mehr, H. et al. GATA 3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13, 141-152 (2008
142. Lin, A. W. et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/ MAPK mitogenic signaling. Genes Dev. 12, 3008-3019 (1998
143. Sang, L., Coller, H. A. & Roberts, J. M. Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science 321, 1095-1100 (2008
144. Xue, W. et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656-660 (2007
145. Narita, M. et al. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 126, 503-514 (2006
146. Coller, H. A., Sang, L. & Roberts, J. M. A new description of cellular quiescence. PLoS Biol. 4, e83 (2006
147. Kaplan, R. N. et al. VEGFR1 positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827 (2005
148. Sharma, S. V. et al. A common signaling cascade may underlie "addiction" to the Src, BCR-ABL, and EGF receptor oncogenes. Cancer Cell 10, 425-435 (2006
149. Sharma, S. V. et al. A chromatin-mediated reversible drug-Tolerant state in cancer cell subpopulations. Cell 141, 69-80 (2010
150. Stoecklein, N. H. et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 13, 441-453 (2008
151. Marlow, R. et al. A novel model of dormancy for bone metastatic breast cancer cells. Cancer Res. 73, 6886-6899 (2013
152. Pardee, A. D. et al. A therapeutic OX40 agonist dynamically alters dendritic, endothelial, and T cell subsets within the established tumor microenvironment. Cancer Res. 70, 9041-9052 (2010
153. Aguirre-Ghiso, J. A., Liu, D., Mignatti, A., Kovalski, K. & Ossowski, L. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol. Biol. Cell 12, 863-879 (2001